Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE: 300026)
China
· Delayed Price · Currency is CNY
4.170
-0.190 (-4.36%)
Nov 14, 2024, 3:04 PM CST
Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China and internationally.
The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, healthcare services, and smart supply chain for pharmaceutical and medical devices.
It provides its products in the areas of severe disease, cardiovascular, cerebrovascular system, respiratory system, neurodegenerative, and anti-tumor.
The company was founded in 1996 and is based in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Co.,Ltd
Country | China |
Founded | 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 5,910 |
CEO | Dan Zheng |
Contact Details
Address: Building B01, Entrepreneurial Headquarters Base Tianjin, 301700 China | |
Phone | 86 22 5962 3160 |
Website | chasesun.cn |
Stock Details
Ticker Symbol | 300026 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100000GF1 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dan Zheng | GM and Vice Chairman |
Wu Jun Lan | Executive GM, Chief Financial Officer and Executive Director |
Wu Sun | Deputy GM, Accounting Supervisor and Director |
Chun Xu Li | Deputy GM, Chief Administrative Officer and Director |
Rui Qiang Chen | GM of Human Resource Center and Deputy GM |
Kun Zhang | Deputy General Manager |
Xiao Zhong Lu | Deputy General Manager |